article thumbnail

Medical Journals Refuse to Retract Fraudulent Trial Reports That Omitted Suicidal Events in Children

Mad in America

We cited research based on the clinical study reports the manufactures had submitted to drug regulators to get their drugs approved for children and adolescents and other research in our letter. 4,5 I asked Emslie and the manufacturer, Eli Lilly, if they wanted to restore the trials. The fraud was grave.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

In 2012, the US Centers for Disease Control reported that 25% of Americans have a mental illness. Avoid financial conflicts of interest with manufacturers of psychoactive drugs or other treatments, e.g. equipment for electroshock. 699 We must put an end to this insanity in a profession that is supposed to take care of the insane.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Clinical, Social, and Cultural Harm of an Iatrogenic Psychiatry

Mad in America

The DSM manufactures illness from normal human reactions by some individuals in response to some environments. While modern medicine has become increasingly impersonal, bureaucratized, and socially iatrogenic, the essence of psychiatry has long been one of social iatrogenesis.

article thumbnail

Review of Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule

Real Psychiatry

Supplementary 1: The more I thought about the figure quoted for precursor amounts used in the illicit manufacture of ketamine in China - the more skeptical I became. doi: 10.1515/revneuro-2012-0078. Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule. Washington DC. American Psychiatric Publishing. 2024; 295 pp.

article thumbnail

From the Dopamine Theory to the Outcomes Paradox

Mad in America

Schizophrenia’ Disability-adjusted life years, 2012 ( Source ) Here I take psychotropic medicine use in general as a proxy for use of ‘antipsychotic’ drugs. China, obviously, has its own large manufacturing capacity. This is most likely under-reporting. The Lancet data is based on sales data from European market research.